Literature DB >> 10722556

Angiographic documented coronary arterial spasm in absence of critical coronary artery stenoses in a patient with variant angina episodes during exercise and dobutamine stress echocardiography.

M Roffi1, B Meier, Y Allemann.   

Abstract

Dobutamine stress echocardiography is widely performed as a useful diagnostic tool in patients with known or suspected coronary artery disease. Dobutamine induced myocardial ischaemia is frequently associated with ST segment depression. ST segment elevation is uncommon and is almost always associated with prior myocardial infarction or transient total coronary occlusion. Dobutamine induced ST segment elevation in absence of significant coronary artery disease is a rare condition and is supposed to be a consequence of severe coronary artery spasm. The case of a 58 year old man with variant angina episodes at rest, during exercise test, and dobutamine stress echocardiography is reported, in whom coronary spasm without significant coronary artery stenoses was documented angiographically.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722556      PMCID: PMC1729367          DOI: 10.1136/heart.83.4.e4

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Dobutamine-induced ST segment elevation and ventricular fibrillation with nonsignificant coronary artery disease.

Authors:  J Shaheen; B Mendzelevski; D Tzivoni
Journal:  Am Heart J       Date:  1996-11       Impact factor: 4.749

2.  A case of dobutamine-induced coronary arterial spasm with ST-segment elevation.

Authors:  H Yamagishi; H Watanabe; I Toda; M Yoshiyama; K Akioka; M Teragaki; K Takeuchi; J Yoshikawa
Journal:  Jpn Circ J       Date:  1998-02

3.  Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease.

Authors:  M Kamalesh; K Chandrasekaran; C A Sivaram; U Thadani
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

4.  Hyperventilation as a specific test for diagnosis of coronary artery spasm.

Authors:  K Nakao; M Ohgushi; M Yoshimura; K Morooka; K Okumura; H Ogawa; K Kugiyama; Y Oike; K Fujimoto; H Yasue
Journal:  Am J Cardiol       Date:  1997-09-01       Impact factor: 2.778

5.  The clinical significance of exercise-induced ST-segment elevation.

Authors:  R A Chahine; A E Raizner; T Ishimori
Journal:  Circulation       Date:  1976-08       Impact factor: 29.690

6.  AHA president's letter.

Authors:  S C Smith
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

7.  Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation.

Authors:  A Elhendy; M L Geleijnse; J R Roelandt; R T van Domburg; J H Cornel; F J TenCate; J Postma-Tjoa; A E Reijs; G M el-Said; P M Fioretti
Journal:  Am J Cardiol       Date:  1995-09-01       Impact factor: 2.778

8.  Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant.

Authors:  M Nobuyoshi; M Abe; H Nosaka; T Kimura; H Yokoi; N Hamasaki; T Shindo; K Kimura; T Nakamura; Y Nakagawa
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

9.  Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography.

Authors:  H Yasue; M Touyama; H Kato; S Tanaka; F Akiyama
Journal:  Am Heart J       Date:  1976-02       Impact factor: 4.749

10.  Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention.

Authors:  C M Fuller; A E Raizner; R A Chahine; P Nahormek; T Ishimori; M Verani; A Nitishin; D Mokotoff; R J Luchi
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

  10 in total
  1 in total

1.  Coronary artery spasm following dobutamine stress echocardiogram.

Authors:  Annick Judenherc Haouzi; Stefani Schwartz; Edward Liszka
Journal:  BMJ Case Rep       Date:  2020-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.